scholarly journals Analysis of non-respondent pregnant women who were registered in the Japan Environment and Children’s Study: a longitudinal cohort study

BMJ Open ◽  
2019 ◽  
Vol 9 (6) ◽  
pp. e025562
Author(s):  
Mika Kigawa ◽  
Akiko Tsuchida ◽  
Kayoko Miura ◽  
Mika Ito ◽  
Tomomi Tanaka ◽  
...  

ObjectivesNon-response to questionnaires in a longitudinal study reduces the effective sample size and introduces bias. We identified the characteristics of non-respondent pregnant women, and compared them with respondents in the Japan Environment and Children’s Study (JECS) during the gestational period.DesignThis was a questionnaire-based, longitudinal cohort study.SettingQuestionnaires were provided by research coordinators to mothers at prenatal examinations (at obstetrics clinics) or by mail. Mothers were measured twice: during the first trimester and during the second/third trimester.ParticipantsData were collected from the 10 129 participating mothers of the 10 288 children surveyed in the 2011 baseline JECS. We excluded responses from mothers who had a miscarriage or stillbirth; therefore, we analysed data from 9649 participants.Primary and secondary outcome measuresData concerning demographics, medical history, health characteristics, health-related behaviour and environmental exposure were collected via self-administered questionnaires. The response status of participants’ partners and contact with their obstetrician were also examined. Multivariate logistic regression analysis was used to examine factors related to non-response.ResultsResponse was associated with living with one’s mother-in-law (ORs: 0.47, 95% CIs: 0.24 to 0.85), positive participation of participants’ partner (OR: 0.25, 95% CI: 0.17 to 0.35) and multiple visits to the obstetrician (OR: 0.02, 95% CI: 0.02 to 0.03). Participants who had a medical history of allergic rhinitis, had body pain or drank alcohol had higher odds of responding (ORs: 0.68, 0.96 and 0.36, 95% CIs: 0.48 to 0.95 and 0.95 to 0.98 and 0.16 to 0.72, respectively); those exposed to secondary smoke had lower odds of responding (OR: 1.59, 95% CI: 1.12 to 2.23).ConclusionsThe non-response rate decreased when participants reported health-related behaviour or characteristics. Obtaining the understanding of people around each participant might help increase response rates.

2020 ◽  
Vol 4 (11) ◽  
pp. e530-e537
Author(s):  
Haotian Wu ◽  
Marianthi-Anna Kioumourtzoglou ◽  
Allan C Just ◽  
Itai Kloog ◽  
Alison Sanders ◽  
...  

2016 ◽  
Vol 26 (3) ◽  
pp. 189-196 ◽  
Author(s):  
Sonia Messina ◽  
Gian Luca Vita ◽  
Maria Sframeli ◽  
Stefania Mondello ◽  
Elena Mazzone ◽  
...  

BMJ Open ◽  
2018 ◽  
Vol 8 (8) ◽  
pp. e022571
Author(s):  
Rajesh Peter ◽  
Dominic Bright ◽  
Wai-Yee Cheung ◽  
Stephen D Luzio ◽  
Gareth J Dunseath

IntroductionGestational diabetes mellitus (GDM) is a common metabolic disorder occurring in up to 10% of pregnancies in the western world. Most women with GDM are asymptomatic; therefore, it is important to screen, diagnose and manage the condition as it is associated with an increased risk of maternal and perinatal complications. Diagnosis of GDM is made in the late second trimester or early third trimester because accurate diagnosis or risk stratification in the first trimester is still lacking. An increase in serum proinsulin may be seen earlier in pregnancy and before a change in glycaemic control can be identified. This study will aim to establish if fasting proinsulin concentrations at 16–18 weeks gestation will help to identify or risk stratify high-risk pregnant women with GDM.Methods and analysisThis is a prospective, longitudinal cohort study. Two oral glucose tolerance tests will be carried out at 16–18 and 24–28 weeks gestation in 200 pregnant women with at least one risk factor for GDM (body mass index>30 kg/m2, previous macrosomic baby (>4.5 kg), previous gestational diabetes, first degree relative with type 2 diabetes mellitus) recruited from antenatal clinics. Blood samples will be taken fasting and at 30 min, 1 and 2 hours following the 75 g glucose load. In addition, a fasting blood sample will be taken 6-weeks post delivery. All samples will be analysed for glucose, insulin, C peptide and proinsulin. Recruitment began in November 2017. Optimal cut-off points for proinsulin to diagnose gestational diabetes according to National Institute for Health and Care Excellence (2015) criteria will be established by the receiver operating characteristic plot and sensitivity and specificity will be calculated to assess the diagnostic accuracy of proinsulin at 16–18 weeks gestation.Ethics and disseminationThis study received ethical approval from the Wales Research Ethics Committee (Panel 6) (Ref. 17/WA/0194). Data will be presented at international conferences and published in peer-reviewed journals.Trial registration numberISRCTN16416602; Pre-results.


Sign in / Sign up

Export Citation Format

Share Document